SANA vs SYRE

Head-to-Head Stock Analysis & Investment Rating

Last Updated: Oct 22, 2026

SANA

60.2
AI Score
VS
SANA Wins

SYRE

38.3
AI Score

Investment Advisor Scores

SANA

60score
Recommendation
BUY

SYRE

38score
Recommendation
SELL

AI Analyst Insights

AI insights temporarily unavailable

Detailed Metrics Comparison

Metric SANA SYRE Winner
Net Income -110.84M -155.20M SANA
Operating Income -114.03M -209.56M SANA
ROE -71.7% -21.7% SYRE
ROA -25.7% -20.0% SYRE
Total Assets 431.52M 777.78M SYRE
Cash 57.07M 85.72M SYRE
Current Ratio 1.38 13.25 SYRE

Relative Price Performance (Last 90 Days)

SANA 1M: -23.1% · 3M: -25.5% SYRE 1M: +4.7% · 3M: -9.6%

Current Technical Phase

SANA

Markdown
Sell / avoid

Price below a falling SMA50 (slope -7.8%), weak momentum, RSI 33

RSI (14): 33.2 · Price: $2.37

SYRE

Neutral
Hold

Mixed signals - no dominant trend phase, RSI 57

RSI (14): 57.2 · Price: $92.33

Fundamentals Snapshot

Metric SANA SYRE
Market Cap — —
Forward P/E -4.3 -26.3
Trailing P/E — —
Revenue (TTM) — —
Revenue Growth 0.0% 0.0%
Gross Margin — —
Operating Margin 0.0% 0.0%
EPS -0.76 -1.95
Dividend Yield — —

Frequently Asked Questions

Based on our detailed analysis, SANA is currently the stronger investment candidate, winning 2 of the key financial metrics based on our comprehensive scoring model.

We analyze revenue and earnings growth rates in the "Growth" section above. Generally, the company with higher year-over-year revenue and EPS growth is fostering better expansion. Check the table above for the specific growth percentages.

Valuation is determined by metrics like the P/E Ratio and PEG Ratio. A lower P/E typically suggests a stock is cheaper relative to its earnings. Refer to the "Valuation" section in our comparison table to see which stock currently trades at a more attractive multiple.